scholarly journals Acute Refractory Hypotension 24 Hours Post-Inferior Vena Cave Filter Insertion Complicated by Early Phlegmasia Cerulea Dolens

2015 ◽  
Vol 6 (8) ◽  
pp. 353-357
Author(s):  
Dou-Anne Siew ◽  
Daniele Wiseman ◽  
Richard Hilsden ◽  
Ranko Bulatovic ◽  
Raymond Kao

2017 ◽  
Vol 22 (6) ◽  
pp. 512-517 ◽  
Author(s):  
Jieun Kang ◽  
Heung-Kyu Ko ◽  
Ji Hoon Shin ◽  
Gi-Young Ko ◽  
Kyung-Wook Jo ◽  
...  

Retrievable inferior vena cava (IVC) filters are increasingly used in patients with venous thromboembolism (VTE) who have contraindications to anticoagulant therapy. However, previous studies have shown that many retrievable filters are left permanently in patients. This study aimed to identify the common indications for IVC filter insertion, the filter retrieval rate, and the predictive factors for filter retrieval attempts. To this end, a retrospective cohort study was performed at a tertiary care center in South Korea between January 2010 and May 2016. Electronic medical charts were reviewed for patients with pulmonary embolism (PE) who underwent IVC filter insertion. A total of 439 cases were reviewed. The most common indication for filter insertion was a preoperative/procedural aim, followed by extensive iliofemoral deep vein thrombosis (DVT). Retrieval of the IVC filter was attempted in 44.9% of patients. The retrieval success rate was 93.9%. History of cerebral hemorrhage, malignancy, and admission to a nonsurgical department were the significant predictive factors of a lower retrieval attempt rate in multivariate analysis. With the increased use of IVC filters, more issues should be addressed before placing a filter and physicians should attempt to improve the filter retrieval rate.



2013 ◽  
Vol 2013 (apr10 1) ◽  
pp. bcr2013009302-bcr2013009302 ◽  
Author(s):  
J. D. Bagenal ◽  
D. Nasralla


2002 ◽  
Vol 16 (2) ◽  
pp. 193-196 ◽  
Author(s):  
E. Baylor Woodward ◽  
Alik Farber ◽  
Willis H. Wagner ◽  
David V. Cossman ◽  
J. Louis Cohen ◽  
...  


2021 ◽  
Vol 233 (5) ◽  
pp. S321-S322
Author(s):  
Ganesh N. Ramakrishnan ◽  
Kevin S. Yei ◽  
Zachary Enumah ◽  
Antonios Gasparis ◽  
Mahmoud Malas


2021 ◽  
Author(s):  
Elisabeth Ekkel ◽  
Tara Chandran ◽  
Ryan Qasawa ◽  
Michael Trpkovski ◽  
Sachinder Hans

Abstract This case is of a young female with a large uterine leiomyoma causing phlegmasia cerulea dolens with thrombosis of the left common and left external iliac veins. She underwent mechanical thrombectomy to temporize the condition until she could be evaluated by gynecology-oncologist to remove the cause of venous obstruction. Prior to hysterectomy, suprarenal inferior vena cava filter was placed. Less than 12 hours post hysterectomy she developed recurrent thrombosis involving the left common and external iliac veins. She underwent repeat mechanical thrombectomy with wall stent placement in the left common iliac vein with resolution of her symptoms.



Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 1776-1776 ◽  
Author(s):  
Henny Heisler Billett ◽  
Noah Kornblum ◽  
Laurie Jacobs ◽  
Nicholas Gargiulo

Abstract Inferior vena cava (IVC) filters are an increasingly popular option for patients with thrombosis and the advent of temporary filters may make this procedure an even more desirable alternative. We decided to evaluate how patients with inferior vena cava filters fared when compared to patients without such filters. A new software program, Clinical Looking Glass, replicates hospital records for statistical access with or without identifiers as defined by IRB-approved protocols. A cohort of patients who had a discharge diagnosis of deep venous thrombosis (DVT) and who had had an IVC filter insertion from 10/1/97 until 5/19/04 was defined. Within this group, a subgroup who had a filter and who had anticoagulation (AC) with an INR between 1.5 and 10 within 3650 days after filter were defined (F-AC) and within this group, a further subgroup whose INR values were between 1.5 and 10 within one year of filter insertion were defined. (F-AC 1YR). Those patients with filters but without any elevations in their INR were classified as ‘Filter - No AC’. The comparison groups were patients without filters who were discharged with a diagnosis of DVT and whose INR values were between 1.5 and 10 within the first year (DVT-AC 1YR). All patients were analyzed for their readmission rates for any diagnosis, for readmission for DVT, and for mortality. 749 patients were classified as DVT- AC 1YR, 533 patients as Filter - No AC, 103 patients as F-AC, and 63 patients as F-AC 1YR. Patients with inferior vena cava filters and anticoagulation were readmitted with the diagnosis of DVT significantly more often than patients without inferior vena cava filters (p<0.0003, RR 1.75 (95%CI 1.51, 2.03), and the mortality tended to be higher at 1 yr (p=.051). In comparison, the group with filter and no anticoagulation had a lower rate of readmission (23.3%, p vs. filter AC p<1x10−8, p vs. DVT AC 1 Yr <0.0003). DVT-AC 1 Yr F-AC 1 YR Filter - No AC Total 749 63 533 Readmissin Rate (n,%) 261 (34.8%) 35 (56%) 124 (23.3%) Days to Readmission 276.8 190 455.3 Mortality at 1 yr 12% 18% Mortality at 5 yr 15% 38% Median Age (yrs) 64 66 75 Readmission for any Dx (n,%) 496 (66.2%) 55 (87.3%) 309 (60.0%) DVT Incidence Density 0.51 0.90 0.21 When 5-year mortality was analyzed for those patients with an IVC filter who were not anticoagulated (Filter -No AC) vs. those who were (F-AC 1YR), there was a very significant difference in favor of anticoagulation but when these were age adjusted (initial median age difference 75yr vs. 66 yrs respectively), no differences were noted. There was no significant gender difference in readmissions for filter patients with or without anticoagulation. For patients with anticoagulation only, a mild gender difference in readmission rate was demonstrated (female: male 41%: 32%, n=785, p<0.04). Although this study suggests that filters with AC do not give added benefit over simple AC to patients, these preliminary analyses have not been performed incorporating severity of illness, indication for filter placement, comorbidities, time in therapeutic AC range or duration of anticoagulation. These retrospective analyses are forthcoming but these preliminary data suggest that a controlled prospective study which examines the efficacy of inferior vena cava filters with and without anticoagulation is necessary to determine its role in antithrombotic therapy.



Sign in / Sign up

Export Citation Format

Share Document